MHRA recalls Ramipril 10mg batch over packaging error
→Dispensers must block Ramipril batch GR174091 from supply immediately
Change
UK's MHRA issued a Class 2 recall for Ramipril 10mg batch GR174091 after some cartons may contain Ramipril 5mg blister strips.
Why it matters
The packaging error can place lower-strength medicine inside 10mg cartons. Pharmacies must stop supply and return remaining stock to suppliers. Patients with batch GR174091 should verify pack contents against carton labelling.
Implications
- → Dispensing teams must quarantine batch GR174091 - supply risks giving patients the wrong Ramipril strength.
- → Inventory teams must inspect affected cartons against blister labels - mismatched packs require pharmacy escalation.
- → Pharmacy returns teams must return remaining batch GR174091 stock - retained packs keep wrong-strength exposure live.
Full decision brief
Unlock the decision layer.
Get the implications, affected teams, what to watch, and Clarify with AI — so the change becomes easier to act on.
Implications — what this change may force you to review
Who is affected — which people, workflows, or obligations are touched
What to watch — dates, deadlines, and triggers that matter next
Real-time alerts — delivered when a decision-forcing change is published
Clarify with AI — ask what this change means for you
Source
View on UK Government